Exelixis Inc (NAS:EXEL)
$ 35.8372 -0.0128 (-0.04%) Market Cap: 10.23 Bil Enterprise Value: 9.22 Bil PE Ratio: 22.97 PB Ratio: 4.50 GF Score: 91/100

Exelixis Inc at Jefferies Healthcare Conference Transcript

Jun 07, 2023 / 02:30PM GMT
Release Date Price: $19.27 (-1.28%)
Akash Tewari
Jefferies LLC, Research Division - Equity Analyst

All right. Good morning, everyone. For those who don't know me, my name is Akash Tewari, a pharma and biotech analyst here at Jefferies. I hope you guys are all enjoying our health care conference and the weather outside. It looked like kind of -- it looked like Blade Runner, it was a little surreal. But anyway, I have the pleasure of hosting Exelixis and Mike Morrissey, President and CEO. Mike, maybe I'll hand it off to you for some brief introductions, and then we'll get into some Q&A.

Michael M. Morrissey
Exelixis, Inc. - CEO, President & Director

Good. Sounds good. Good morning, everybody. Again, Mike Morrissey, Exelixis. Before I begin, I'll be making forward-looking statements today, so please see our SEC filings for a description of the risks that we face in our business. Go ahead.

Questions & Answers

Akash Tewari
Jefferies LLC, Research Division - Equity Analyst

Perfect. All right. So you and I were both at ASCO, our -- and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot